Amundi boosted its holdings in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 193.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,828 shares of the financial services provider's stock after purchasing an additional 11,088 shares during the quarter. Amundi's holdings in Trupanion were worth $784,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the business. FMR LLC boosted its holdings in Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Baillie Gifford & Co. boosted its holdings in Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock worth $33,806,000 after acquiring an additional 147,341 shares during the last quarter. Wellington Management Group LLP boosted its holdings in Trupanion by 4.4% during the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider's stock worth $142,475,000 after acquiring an additional 142,156 shares during the last quarter. DF Dent & Co. Inc. boosted its holdings in Trupanion by 27.8% during the 3rd quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider's stock worth $15,443,000 after acquiring an additional 80,014 shares during the last quarter. Finally, Hosking Partners LLP boosted its holdings in Trupanion by 52.5% during the 4th quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider's stock worth $10,253,000 after acquiring an additional 73,203 shares during the last quarter.
Insider Activity at Trupanion
In other news, CFO Fawwad Qureshi sold 1,373 shares of the company's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the sale, the chief financial officer now directly owns 2,416 shares in the company, valued at $82,675.52. This represents a 36.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Brenna Mcgibney sold 5,000 shares of the company's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total value of $164,950.00. Following the sale, the insider now owns 3,738 shares in the company, valued at approximately $123,316.62. This represents a 57.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,984 shares of company stock worth $850,362. Company insiders own 5.50% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on TRUP. Stifel Nicolaus cut their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Piper Sandler cut their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Trupanion presently has a consensus rating of "Moderate Buy" and an average target price of $46.60.
View Our Latest Research Report on Trupanion
Trupanion Stock Performance
Trupanion stock traded up $0.22 during midday trading on Friday, reaching $37.00. The stock had a trading volume of 487,452 shares, compared to its average volume of 640,279. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The firm's 50-day moving average price is $41.64 and its 200 day moving average price is $46.73. The firm has a market capitalization of $1.57 billion, a PE ratio of -160.87, a P/E/G ratio of 6.02 and a beta of 1.70. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. As a group, research analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.
Trupanion Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.